Media Center

Latest from the Blogs

  1. June 14, 2018

    Potential Brain Tumor Treatments Entering the Pivotal Phase of Evaluation – June 2018

    A large, randomized, controlled Phase III clinical trial is traditionally the last, pivotal step in the evaluation of a potential new medicine before it is approved for use by all patients with the indicated disease. A year ago, the NBTS staff conducted and published a review of all the Phase III clinical trials for glioblastoma […]

    Read more | 
  2. June 13, 2018

    NBTS Brain Tumor Clinical Trials Report: Q2 2018

    New brain tumor clinical trials open around the country all the time, and it can be hard for patients and care-partners to keep track of new opportunities to potentially participate in leading-edge clinical research. This report, generated by the National Brain Tumor Society, provides you with a summary of clinical trials that have started or […]

    Read more | 

Media Contacts

If you need additional information, have a specific request, or would like a comment from National Brain Tumor Society, please use the contacts below:

Michael Antonellis
National Director of Marketing Communications
617.393.2841
mantonellis@braintumor.org

Tom Halkin
Senior Manager of Communications
617.393.2849
thalkin@braintumor.org

Share